Can EGCG reduce abdominal fat in obese subjects? - Wikidata - wikimedia - TriplyDB

Can EGCG reduce abdominal fat in obese subjects?

Can EGCG reduce abdominal fat in obese subjects?

http://www.wikidata.org/entity/Q46974080

about

Green tea for weight loss and weight maintenance in overweight or obese adults Effect of green tea consumption on blood pressure: a meta-analysis of 13 randomized controlled trials Short-term weight-centric effects of tea or tea extract in patients with metabolic syndrome: a meta-analysis of randomized controlled trials Vascular and metabolic actions of the green tea polyphenol epigallocatechin gallate Liver-related safety assessment of green tea extracts in humans: a systematic review of randomized controlled trials Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome.Epigallocatechin-3-gallate increases maximal oxygen uptake in adult humans.Coffee mannooligosaccharides, consumed as part of a free-living, weight-maintaining diet, increase the proportional reduction in body volume in overweight men Fat burners: nutrition supplements that increase fat metabolism.Green tea polyphenols reduce body weight in rats by modulating obesity-related genes.Green Tea Extract Rich in Epigallocatechin-3-Gallate Prevents Fatty Liver by AMPK Activation via LKB1 in Mice Fed a High-Fat Diet Long-Term Supplementation of Green Tea Extract Does Not Modify Adiposity or Bone Mineral Density in a Randomized Trial of Overweight and Obese Postmenopausal Women.Acute effects of ingesting a commercial thermogenic drink on changes in energy expenditure and markers of lipolysis.Inhibition of starch digestion by the green tea polyphenol, (-)-epigallocatechin-3-gallate.Tea and health: preventive and therapeutic usefulness in the elderly?Greenselect phytosome for borderline metabolic syndrome.Novel insights of dietary polyphenols and obesity The putative effects of green tea on body fat: an evaluation of the evidence and a review of the potential mechanisms.Geriatric obesity: evaluating the evidence for the use of flavonoids to promote weight loss.A natural solution for obesity: bioactives for the prevention and treatment of weight gain. A review.The anti-obesity effects of green tea in human intervention and basic molecular studies.Therapeutic effects of EGCG: a patent review.Therapeutic potential of green tea on risk factors for type 2 diabetes in obese adults - a review.Catechins and Its Role in Chronic Diseases.Minor effects of green tea catechin supplementation on cardiovascular risk markers in active older people: a randomized controlled trial.Effects of green tea catechin extract on serum lipids in postmenopausal women: a randomized, placebo-controlled clinical trial.Effects of catechin enriched green tea on body composition.Effect of moderate intakes of different tea catechins and caffeine on acute measures of energy metabolism under sedentary conditions.The anti-obesity effects of EGCG in relation to oxidative stress and air-pollution in China.Scientific Opinion on the substantiation of health claims related to Camellia sinensis (L.) Kuntze (tea), including catechins from green tea, and contribution to the maintenance or achievement of a normal body weight (ID 1107, 1112, 1544, 2716), i...Phenolic compounds as natural and multifunctional anti-obesity agents: A review.Green tea (-)-epigallocatechin-3-gallate counteracts daytime overeating induced by high-fat diet in mice.Green tea beverages enriched with catechins with a galloyl moiety reduce body fat in moderately obese adults: a randomized double-blind placebo-controlled trial.Influence of short-term consumption of the caffeine-free, epigallocatechin-3-gallate supplement, Teavigo, on resting metabolism and the thermic effect of feeding.(-)-Epigallocathechin-3-gallate, an AMPK activator, decreases ovariectomy-induced bone loss by suppression of bone resorption.Polyphenols and their effects on diabetes management: A review.

P2860

Q24202274-91700323-0EDA-40FA-B8FA-708C7FE10F27 Q24563840-EF3A4CE7-AFB4-4326-8F6B-1A5D03414194 Q26852426-CB322463-4390-4E0C-BE1E-980FFED5E637 Q26995055-4F5EC64F-DD64-42F0-98F3-F21D0FD9CFBD Q30242061-1B5646EF-84BC-427C-9A34-7A98C91C40D2 Q33623283-A81DA2F1-B7F7-4C8D-86D7-442A11494191 Q33956808-478D7A40-5C4D-4EA8-A15A-20018E9AE7C9 Q34204384-8A835F99-E80E-49AF-AC46-B04F9454DE86 Q34219680-369462EE-1FF6-443D-A52D-6DF08FF7BD1E Q34310244-A7085C43-0BB5-4126-B1B9-422BAC9DCE20 Q35832166-4F63673E-A6F8-48B8-A051-A19E80C2E328 Q36498024-038B4A72-D692-4CE6-ABEE-71D8D5D6BF2C Q36512475-582EFF60-2593-4DA5-B69D-653C94BAB756 Q36931697-BA4960F6-B0A7-4C91-BB34-771296D97600 Q37233670-9BF9CCC2-11A2-40F1-AB50-7EE22D408F66 Q37358523-79F1B8BA-E6D9-4E77-B11E-2044AB92CB56 Q37588979-8DD035D3-7472-4025-B644-274BEEFD18A4 Q37910326-AEDBF2D1-95C1-474B-A8B9-4702000318FA Q38034248-EB21E0ED-4E70-48CA-98C7-35D15FA25222 Q38195322-4053FD83-D406-4161-9228-AABB3EB476CC Q38235202-42602D14-0CD7-464E-8474-27034F766B8E Q38762634-8CCC9024-F7F6-45FC-8592-56A0028D1A9F Q38904568-B8377F65-52A9-49EA-9B39-D6174C023C5C Q38988558-C1F81C61-6A08-4665-94F7-ABDD0401EFBD Q39542245-020B48D7-0A29-4412-ACD2-0773832110B2 Q40494718-69795E0B-ABCA-4DD5-9B8E-92B082FAB732 Q43292223-2C5EC6EE-CDCF-4E0A-91BD-80D803645DDB Q46010023-4C15DA84-2616-496D-9146-15DA33EB04B1 Q46096053-393AA720-60F1-4DC8-A269-1C080EBCDD5B Q47148903-D8E65A60-6C28-480B-AD52-A6D4E41D5BC4 Q48269956-0AE7AB49-8019-45C2-88FE-EAC9C94E1490 Q48598795-A3B569C8-9158-4602-B510-FFB9CF6DB398 Q50239189-D9001646-29B4-452B-AC68-BB446559F5E5 Q50543116-AAB03FF7-E6BA-4E9C-8076-5C7F26C93F67 Q51351954-9CD8D29F-1975-4519-A156-9A8B266ECF44 Q55285286-91EB8ECE-BA11-4C4F-9BBE-21F8F3D35866

P2860

Can EGCG reduce abdominal fat in obese subjects?

http://www.wikidata.org/entity/Q46974080

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Can EGCG reduce abdominal fat in obese subjects?

@en

Can EGCG reduce abdominal fat in obese subjects?

@nl

type

label

Can EGCG reduce abdominal fat in obese subjects?

@en

Can EGCG reduce abdominal fat in obese subjects?

@nl

prefLabel

Can EGCG reduce abdominal fat in obese subjects?

@en

Can EGCG reduce abdominal fat in obese subjects?

@nl

P1433

Q46974080-EE66F9A7-3576-4DC0-9707-F484E454B2F6

P1476

Q46974080-9AE64A93-C6EB-4BB5-9A86-B10E419DFA74

P2093

Q46974080-5669FA9F-639C-4794-BF0F-E6B64EA3744F

Q46974080-58BF000F-E14E-462D-94DE-2E35FAA159A0

Q46974080-6A9FA70D-7273-40C1-85C2-E20F36ACA78D

Q46974080-887CED9A-D10D-452C-BBD0-AA60932DC396

Q46974080-A6BEDD01-9273-41D9-ADAA-779C6CDA6182

Q46974080-A9E7A198-0F55-41DD-9E27-F6C2E77EBF2E

P2860

Q46974080-04F55A5B-F77A-4728-8767-6D1D61D489B3

Q46974080-2B10AF75-DBED-42DA-AC91-D8B0B6407B4C

Q46974080-33EB9D22-5953-4628-BF50-67686B4E9022

Q46974080-4F8E3F10-6395-4B56-8DA7-7A4AE39664F5

Q46974080-5F52DA7B-17BB-42C4-A448-B940D7B3DEE3

Q46974080-6CB3A226-2070-4BAF-9306-E2FC9F0450E4

Q46974080-6E05B28F-A3E8-4817-B9D2-B98BA825D30E

Q46974080-932804D8-E8B7-41A3-A645-676DDF678AF4

Q46974080-C02E9AC5-405F-40E3-8261-599E28B978DB

Q46974080-C582FDB0-2275-47C5-B3B1-67AB506DC51C

P304

Q46974080-DF3286CE-3AE9-4E36-A483-22ED059EF219

P31

Q46974080-F00960DB-60F5-4458-8EAA-2D3100960181

P356

Q46974080-46F5B3C5-0517-4AF5-9C45-96B9F27705CF

P433

Q46974080-BB88D4A3-BD43-4654-B84E-CAEC33A102B6

P478

Q46974080-C9553861-ABAB-4664-AFDC-FAC4BBAB05B1

P577

Q46974080-FA30ADA2-7578-481D-9268-9F2BF97745FC

P5875

Q46974080-5DDBEDDE-7FD0-4D34-AA0A-AB255368DE53

P698

Q46974080-3FDDFDED-48F1-4EA0-90E3-E0857EBB017D

P921

Q46974080-D9052B51-1EB3-4B9A-85E6-B520090D302C

P356

07315724.2007.10719628

P1433

Journal of the American College of Nutrition

P1476

Can EGCG reduce abdominal fat in obese subjects?

@en

P2093

Alison M Coates

http://www.w3.org/2001/XMLSchema#string

Alison M Hill

http://www.w3.org/2001/XMLSchema#string

Frank Thielecke

http://www.w3.org/2001/XMLSchema#string

Jonathan D Buckley

http://www.w3.org/2001/XMLSchema#string

Peter R C Howe

http://www.w3.org/2001/XMLSchema#string

Robert Ross

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans

Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee

Anti-obesity effects of green tea: from bedside to bench.

Exercise and the nitric oxide vasodilator system.

Green tea, the "Asian paradox," and cardiovascular disease.

Tea and cancer prevention: molecular mechanisms and human relevance

Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity.

Green tea epigallocatechin gallate: a natural inhibitor of fatty-acid synthase.

Powdered green tea has antilipogenic effect on Zucker rats fed a high-fat diet.

Antihyperglycemic effect of oolong tea in type 2 diabetes.

P304

396S-402S

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/07315724.2007.10719628

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5939144

http://www.w3.org/2001/XMLSchema#string

P698

17906193

http://www.w3.org/2001/XMLSchema#string

P921